Frytak S - Search Results

1

Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: preliminary results and suggestions for future study designs.

Jatoi A, Kahanic SP, Frytak S, Schaefer P, Foote RL, Sloan J, Petersen RC. Jatoi A, et al. Among authors: frytak s. Support Care Cancer. 2005 Jan;13(1):66-9. doi: 10.1007/s00520-004-0696-0. Epub 2004 Oct 9. Support Care Cancer. 2005. PMID: 15480814 Clinical Trial.

2

Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management.

Kanard A, Frytak S, Jatoi A. Kanard A, et al. Among authors: frytak s. J Support Oncol. 2004 Mar-Apr;2(2):127-32; discussion 133-5, 138-40. J Support Oncol. 2004. PMID: 15328816 Review.

3

Cerebral toxicity in patients treated for small cell carcinoma of the lung.

Fonseca R, O'Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S. Fonseca R, et al. Among authors: frytak s. Mayo Clin Proc. 1999 May;74(5):461-5. doi: 10.4065/74.5.461. Mayo Clin Proc. 1999. PMID: 10319075

4

Ramifications of severe organ dysfunction in newly diagnosed patients with small cell lung cancer: contemporary experience from a single institution.

Giordano KF, Jatoi A, Adjei AA, Creagan ET, Croghan G, Frytak S, Jett JR, Marks R, Molina J, Okuno S, Richardson RL. Giordano KF, et al. Among authors: frytak s. Lung Cancer. 2005 Aug;49(2):209-15. doi: 10.1016/j.lungcan.2005.01.009. Epub 2005 Apr 13. Lung Cancer. 2005. PMID: 16022915

5

Prophylactic cranial irradiation in limited-stage small cell lung cancer.

Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Richardson RL, Creagan ET, Eagan RT, Su JQ. Liengswangwong V, et al. Among authors: frytak s. Cancer. 1995 Mar 15;75(6):1302-9. doi: 10.1002/1097-0142(19950315)75:6<1302::aid-cncr2820750612>3.0.co;2-e. Cancer. 1995. PMID: 7882280

6

Role of radiation therapy in the management of lung cancer.

Shaw EG, Bonner JA, Foote RL, Martenson JA Jr, Frytak S, Deschamps C, McDougall JC. Shaw EG, et al. Among authors: frytak s. Mayo Clin Proc. 1993 Jun;68(6):593-602. doi: 10.1016/s0025-6196(12)60375-9. Mayo Clin Proc. 1993. PMID: 8388525 Review.

7

Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.

Frytak S, Shaw EG, Jett JR, Richardson RL, Foote RL, Creagan ET, Eagan RT, Su JQ. Frytak S, et al. Am J Clin Oncol. 1996 Apr;19(2):193-8. doi: 10.1097/00000421-199604000-00022. Am J Clin Oncol. 1996. PMID: 8610649 Clinical Trial.

8

Long-term results of a phase I/II study of high-dose thoracic radiotherapy with concomitant cisplatin and etoposide in limited stage small-cell lung cancer.

Brown PD, Bonner JA, Foote RL, Frytak S, Marks RS, Richardson RL, Creagan ET. Brown PD, et al. Among authors: frytak s. Am J Clin Oncol. 2001 Dec;24(6):556-61. doi: 10.1097/00000421-200112000-00005. Am J Clin Oncol. 2001. PMID: 11801753 Clinical Trial.

9

Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.

Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Eagan RT, Jett JR, Richardson RL, Creagan ET, Su JQ. Liengswangwong V, et al. Among authors: frytak s. J Clin Oncol. 1994 Mar;12(3):496-502. doi: 10.1200/JCO.1994.12.3.496. J Clin Oncol. 1994. PMID: 8120547

10

Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.

Shaw EG, Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Foote RL, Su JQ, Schaid DJ, Lee RE. Shaw EG, et al. Among authors: frytak s. Am J Clin Oncol. 1996 Apr;19(2):154-8. doi: 10.1097/00000421-199604000-00013. Am J Clin Oncol. 1996. PMID: 8610640 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page